EyePoint Pharmaceuticals
At close: Aug 18
After Hours: 4:01PM EDT
Day High/Low10.2 - 10.61
52 Week High/Low7 - 14.41
Open / Close10.52 / 10.5
Float / Outstanding21.7M / 34.1M
Vol / Avg.69.7K / 160K
Mkt Cap357.8M
50d Avg. Price9.1
Div / Yield-
Payout Ratio-
Total Float21.7M

EyePoint Pharmaceuticals (NASDAQ:EYPT), Earnings Estimates, EPS, and Revenue

EyePoint Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3



Quarterly Revenue


Annual Revenue (as of Jun 30)


Earnings Recap


EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.


EyePoint Pharmaceuticals reported in-line EPS of $-0.52 versus an estimate of $-0.52.

Revenue was up $2.55 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 6.92% drop in the share price the next day.

Here's a look at EyePoint Pharmaceuticals's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.58 -0.53 -0.40 -0.43
EPS Actual -0.56 -0.59 -0.58 -0.42
Revenue Estimate 9.89M 9.80M 9.84M 9.13M
Revenue Actual 9.29M 11.54M 9.06M 9.01M

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of EyePoint Pharmaceuticals using advanced sorting and filters.

Prior EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert

EyePoint Pharmaceuticals Questions & Answers

When is EyePoint Pharmaceuticals (NASDAQ:EYPT) reporting earnings?

EyePoint Pharmaceuticals (EYPT) is scheduled to report earnings on November 2, 2022. The last reported earnings were for reported on August 3, 2022 for Q2.

What were the latest earnings per share (EPS) for EyePoint Pharmaceuticals (NASDAQ:EYPT)?

The Actual EPS was $-1.60, which missed the estimate of $-1.50.

What were EyePoint Pharmaceuticals’s (NASDAQ:EYPT) revenues?

The Actual Revenue was $701K, which beat the estimate of $470K.

Browse earnings estimates, EPS, and revenue on all stocks.